Stockreport

Candel Therapeutics Has A Protracted, But Real, Timeline To Approval Now [Seeking Alpha]

Candel Therapeutics, Inc.  (CADL) 
PDF In the meantime, the market appears to be anticipating very little forward momentum in other pipeline candidates. CADL presents a high-risk/high-reward situation at t [Read more]